Our three programs offer unique experiences to earn a medical degree. The University (Western Reserve 2) Program, our traditional four-year MD program, is our oldest and largest, offering an ...

Founded in 2008, The Mount Sinai Tisch Cancer Institute first received NCI “Clinical Cancer Center” status in 2015. After a decade of growth in research, clinical trials, and community outreach, Mount ...

The following gastroenterologists lead departments at hospitals ranked among the top 10 for gastroenterology and GI surgery by U.S. News & World Report for 2025-26. James Hamilton, MD, is director of ...

When George Tidmarsh, MD, PhD, director of the FDA's Center for Drug Evaluation and Research, first floated the idea of ...

From the stomach to the colon, researchers are uncovering how shifts in the gut microbiome may drive cancers across the ...

As Brown sought to identify targets for University-wide budget cuts in the spring and summer, administrators notified leaders ...

The Icahn School of Medicine at Mount Sinai has received a prestigious $4.5 million, five-year K12 award from the National Institutes of Health (NIH) to establish a pioneering program that will train ...

Patient selection should prioritize those with obesity and heart failure with preserved ejection fraction, as benefits for reduced ejection fraction are not yet proven.

Spyre Therapeutics is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (“IBD”) and ...

The event will take place on November 3, 2025 beginning at 10 am ET and will feature presentations by ProQR Management and ...